RPRX — Royalty Pharma plc

RPRXRoyalty Pharma plc

NAS · US · Healthcare · Biotechnology · royaltypharma.com

54.03USD-0.85%Mkt Cap: 31.10B USDP/E: 28.43Last update: 2026-05-26

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed th…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap31.10B USD

Enterprise Value35.15B USD

Revenue (TTM)2.44B USD

Gross Profit2.81B USD

Net Income (TTM)770.95M USD

Revenue/Share5.674 USD

Last Price54.03 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees100

CountryUS

SectorHealthcare

IndustryBiotechnology

ISINGB00BMVP7Y09

Valuation

P/E (Trailing)28.43

P/E (Forward)9.54

PEG1.98

EV/EBITDA—

EV/Revenue14.40

P/S12.63

P/B3.54

EPS (TTM)1.90

EPS (Forward)5.61

52W Range

32.1597% of range54.74

52W High54.74 USD

52W Low32.15 USD

Profitability

Gross Margin115.00%

Oper. Margin100.30%

EBITDA Margin0.00%

Profit Margin32.42%

ROE11.90%

ROA3.93%

Growth

Revenue Growth11.00%

Earnings Growth23.20%

Cash Flow & Leverage

Operating CF2.49B USD

CapEx (TTM)—

FCF Margin-40.17%

FCF Yield-3.15%

Net Debt8.37B USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity1.38

Current Ratio2.66

Quick Ratio2.64

Book Value/Sh15.11 USD

Cash/Share1.372 USD

Dividends

Fwd Div Rate0.9400 USD

Trail. Div Rate0.8950 USD

Div. Yield1.76%

5Y Avg Yield2.29%

Payout Ratio47.11%

Ex-Div DateMay 15, 2026

Pay DateJun 10, 2026

Analyst Consensus

Rating1.5 (Buy)

Target (Mean)59.25 USD

Target Range46.00 USD – 66.00 USD

# Analysts8

Ownership

Shares Out.443.27M

Float434.76M

Insiders7.17%

Institutions85.87%

Short Interest

Short Ratio4.7d

Short % Float3.15%

Short % Out.3.11%

Shares Short13.82M

Short (prev mo.)11.52M

Technical

SMA 5048.96 (+10.4%)

SMA 20041.61 (+29.9%)

Beta0.40

S&P 52W Chg28.31%

Avg Vol (30d)3.35M

Avg Vol (10d)3.62M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—